CompuMed to Provide ECG Telemedicine and CardioGramKids Services to The Saban Free Clinic and School Health Centers System Wide
02 Febbraio 2011 - 2:20PM
CompuMed, Inc. (OTCBB:CMPD)
(http://www.compumed.net), a
telemedicine and
medical informatics company, has entered into an
agreement with The Saban Free Clinic and school health centers to
provide CompuMed's
electrocardiogram (ECG)
telemedicine and
CardioGramKids® services to the
four community clinics and school health centers operated by the
Clinic. Now in its 43rd year, The Saban Free Clinic (formerly The
Los Angeles Free Clinic) provides nearly 90,000 patient visits
annually to the uninsured, teens, and other vulnerable populations
in the Greater Los Angeles area. CompuMed will provide the Clinic
with the company's ECG telemedicine equipment and with over-reads
performed remotely by CompuMed's cardiologists and pediatric
cardiologists.
CompuMed will also provide The Saban Free Clinic with the
company's CardioGramKids Pediatric Screening services at the school
health center the Clinic operates for the Los Angeles Unified
School District at Hollywood High School. CompuMed's CardioGramKids
program was designed in tandem with pediatricians and other
healthcare providers to provide ECG screening services to children
and teenagers prior to taking psychotropic medications or
participating in school or afterschool sports programs.
"We are grateful to CompuMed for significantly enhancing our
ability to provide preventive cardiac health services to the Los
Angeles community," said Donzella Lee, M.P.H., Director of
Operations at The Saban Free Clinic. "With CompuMed's ECG
telemedicine technology, the Clinic can provide patients with
state-of-the-art electrocardiogram analysis services in a
cost-effective and convenient manner," added Lee.
"We are pleased to be working with L.A.'s preeminent community
clinic organization to enhance the delivery of preventive medicine
to the children and adults of Los Angeles," said CompuMed's lead
cardiologist David M. Frisch, M.D., F.A.C.C. "By implementing
CompuMed's ECG telemedicine program system wide, The Saban Free
Clinic is likely to prevent or minimize a large number of acute or
long-term cardiac problems and save lives," Dr. Frisch added.
"With the extension of our ECG telemedicine and CardioGramKids
school health center programs into the major community clinic
organizations, CompuMed continues to play a leading role in
bringing ECG telemedicine to a wide variety of healthcare
settings," said CompuMed CEO Maurizio Vecchione. "It's clear that
the future of healthcare will rely heavily on the Internet and that
companies in the telemedicine field like CompuMed are well
positioned to prosper."
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and
services that combine advanced imaging with medical informatics.
Its focus is on analysis and remote monitoring for patients with
cardiovascular and musculoskeletal diseases. The company has
specialized expertise and intellectual property in telemonitoring
imaging and analysis designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is
headquartered in Los Angeles and distributes its products worldwide
both directly and through OEM partners. Visit CompuMed at
http://www.compumed.net and follow at Twitter: @compumed.
Forward Looking Statements
Statements contained in this press release that are not
historical facts, such as statements about prospective earnings,
savings, revenue, operations, revenue and earnings growth, results
of contracts and other financial results, are forward-looking
statements pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. All such forward-looking
statements including statements concerning the Company's plans,
objectives, expectations and intentions are based largely on
management's expectations and are subject to and qualified by risks
and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements.
These statements are subject to uncertainties and risks including,
without limitation, competitive factors, outsourcing trends in the
pharmaceutical industry, product and service demand and acceptance,
changes in technology, ability to raise capital, the availability
of appropriate acquisition candidates and/or business partnerships,
economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government
regulation and other risks identified in the Company's filings with
the Securities and Exchange Commission including its Annual Report
on Form 10-KSB and Quarterly Reports on Form 10-QSB. All such
forward-looking statements are expressly qualified by these
cautionary statements. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect events,
conditions or circumstances on which any such statement is based
after the date hereof, except as required by law.
CONTACT: Susan Tellem
Tellem Worldwide
+1 310-313-3444
stellem@tellem.com
Grafico Azioni Common Stock (PK) (USOTC:CMPD)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Common Stock (PK) (USOTC:CMPD)
Storico
Da Giu 2023 a Giu 2024